Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

FRA:ACT - DE000A2YNT30 - Common Stock

140.4 EUR
+1.8 (+1.3%)
Last: 9/9/2025, 7:00:00 PM
Fundamental Rating

7

ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 65 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, ACT is valued expensive at the moment. These ratings would make ACT suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ACT had positive earnings in the past year.
In the past year ACT had a positive cash flow from operations.
Each year in the past 5 years ACT has been profitable.
ACT had a positive operating cash flow in 4 of the past 5 years.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.48%, ACT belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
The Return On Equity of ACT (26.66%) is better than 98.46% of its industry peers.
The Return On Invested Capital of ACT (13.72%) is better than 93.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACT is above the industry average of 7.08%.
The last Return On Invested Capital (13.72%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.48%
ROE 26.66%
ROIC 13.72%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 10.43%, ACT belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
ACT's Profit Margin has improved in the last couple of years.
ACT's Operating Margin of 15.34% is amongst the best of the industry. ACT outperforms 84.62% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
With an excellent Gross Margin value of 65.74%, ACT belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
ACT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.34%
PM (TTM) 10.43%
GM 65.74%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ACT has an Altman-Z score of 4.74. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.74, ACT belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
ACT has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.15, ACT belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that ACT is not too dependend on debt financing.
ACT has a Debt to Equity ratio of 0.18. This is in the better half of the industry: ACT outperforms 73.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.15
Altman-Z 4.74
ROIC/WACC1.93
WACC7.1%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ACT has a Current Ratio of 2.84. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
ACT's Current ratio of 2.84 is amongst the best of the industry. ACT outperforms 81.54% of its industry peers.
ACT has a Quick Ratio of 1.73. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.73, ACT is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 1.73
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.65%, which is quite impressive.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.03%.
The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%

3.2 Future

ACT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.50% yearly.
ACT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y16.75%
EPS Next 2Y15.49%
EPS Next 3Y18.99%
EPS Next 5Y19.5%
Revenue Next Year2.96%
Revenue Next 2Y6.07%
Revenue Next 3Y8.52%
Revenue Next 5Y6.02%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.59, ACT is valued on the expensive side.
ACT's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (27.07), we can say ACT is valued inline with the index average.
The Price/Forward Earnings ratio is 20.67, which indicates a rather expensive current valuation of ACT.
ACT's Price/Forward Earnings ratio is in line with the industry average.
ACT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.59.
Industry RankSector Rank
PE 24.59
Fwd PE 20.67
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACT's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 34.56
EV/EBITDA 12.5
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
ACT's earnings are expected to grow with 18.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.47
PEG (5Y)1
EPS Next 2Y15.49%
EPS Next 3Y18.99%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.29%, ACT has a reasonable but not impressive dividend return.
ACT's Dividend Yield is slightly below the industry average, which is at 3.00.
With a Dividend Yield of 1.29, ACT pays less dividend than the S&P500 average, which is at 2.46.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACT pays out 31.40% of its income as dividend. This is a sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.4%
EPS Next 2Y15.49%
EPS Next 3Y18.99%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (9/9/2025, 7:00:00 PM)

140.4

+1.8 (+1.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners40.2%
Ins Owner ChangeN/A
Market Cap1.43B
Analysts81.82
Price Target143.84 (2.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.67%
PT rev (3m)18.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.12%
EPS NY rev (3m)2.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-0.6%
Valuation
Industry RankSector Rank
PE 24.59
Fwd PE 20.67
P/S 2.57
P/FCF 34.56
P/OCF 12.7
P/B 6.58
P/tB 6.69
EV/EBITDA 12.5
EPS(TTM)5.71
EY4.07%
EPS(NY)6.79
Fwd EY4.84%
FCF(TTM)4.06
FCFY2.89%
OCF(TTM)11.06
OCFY7.88%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.47
PEG (5Y)1
Profitability
Industry RankSector Rank
ROA 10.48%
ROE 26.66%
ROCE 19.03%
ROIC 13.72%
ROICexc 16.02%
ROICexgc 16.17%
OM 15.34%
PM (TTM) 10.43%
GM 65.74%
FCFM 7.45%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 270.53%
Cap/Sales 12.82%
Interest Coverage 42.05
Cash Conversion 100.91%
Profit Quality 71.41%
Current Ratio 2.84
Quick Ratio 1.73
Altman-Z 4.74
F-Score7
WACC7.1%
ROIC/WACC1.93
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y16.75%
EPS Next 2Y15.49%
EPS Next 3Y18.99%
EPS Next 5Y19.5%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.96%
Revenue Next 2Y6.07%
Revenue Next 3Y8.52%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%